Authors:
Gure, AO
Stockert, E
Scanlan, MJ
Keresztes, RS
Jager, D
Altorki, NK
Old, LJ
Chen, YT
Citation: Ao. Gure et al., Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer, P NAS US, 97(8), 2000, pp. 4198-4203
Authors:
Jager, E
Gnjatic, S
Nagata, Y
Stockert, E
Jager, D
Karbach, J
Neumann, A
Rieckenberg, J
Chen, YT
Ritter, G
Hoffman, E
Arand, M
Old, LJ
Knuth, A
Citation: E. Jager et al., Induction of primary NY-ESO-1 immunity: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers, P NAS US, 97(22), 2000, pp. 12198-12203
Authors:
Gnjatic, S
Nagata, Y
Jager, E
Stockert, E
Shankara, S
Roberts, BL
Mazzara, GP
Lee, SY
Dunbar, PR
Dupont, B
Cerundolo, V
Ritter, G
Chen, YT
Knuth, A
Old, LJ
Citation: S. Gnjatic et al., Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele, P NAS US, 97(20), 2000, pp. 10917-10922
Authors:
Chen, JL
Dunbar, PR
Gileadi, U
Jager, E
Gnjatic, S
Nagata, Y
Stockert, E
Panicalli, DL
Chen, YT
Knuth, A
Old, LJ
Cerundolo, V
Citation: Jl. Chen et al., Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL, J IMMUNOL, 165(2), 2000, pp. 948-955
Authors:
Jager, E
Jager, D
Karbach, J
Chen, YT
Ritter, G
Nagata, Y
Gnjatic, S
Stockert, E
Arand, M
Old, LJ
Knuth, A
Citation: E. Jager et al., Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB40101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma, J EXP MED, 191(4), 2000, pp. 625-630
Authors:
Rader, C
Ritter, G
Nathan, S
Elia, M
Gout, I
Jungbluth, AA
Cohen, LS
Welt, S
Old, LJ
Barbas, CF
Citation: C. Rader et al., The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies, J BIOL CHEM, 275(18), 2000, pp. 13668-13676
Authors:
Ono, T
Sato, S
Kimura, N
Tanaka, M
Shibuya, A
Old, LJ
Nakayama, E
Citation: T. Ono et al., Serological analysis of BALB/c methylcholanthrene sarcoma Meth A by SEREX:Identification of a cancer/testis antigen, INT J CANC, 88(6), 2000, pp. 845-851
Authors:
Deckert, PM
Jungbluth, A
Montalto, N
Clark, MA
Finn, RD
Williams, C
Richards, EC
Panageas, KS
Old, LJ
Welt, S
Citation: Pm. Deckert et al., Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts, INT J CANC, 87(3), 2000, pp. 382-390
Authors:
Gure, AO
Stockert, E
Arden, KC
Boyer, AD
Viars, CS
Scanlan, MJ
Old, LJ
Chen, YT
Citation: Ao. Gure et al., CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis, INT J CANC, 85(5), 2000, pp. 726-732
Authors:
Clarke, K
Lee, FT
Brechbiel, MW
Smyth, FE
Old, LJ
Scott, AM
Citation: K. Clarke et al., In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice, CANCER RES, 60(17), 2000, pp. 4804-4811
Authors:
Jager, D
Stockert, E
Jager, E
Gure, AO
Scanlan, MJ
Knuth, A
Old, LJ
Chen, YT
Citation: D. Jager et al., Serological cloning of a melanocyte rab guanosine 5 '-triphosphate-bindingprotein and a chromosome condensation protein from a melanoma complementary DNA library, CANCER RES, 60(13), 2000, pp. 3584-3591
Authors:
Scott, AM
Geleick, D
Rubira, M
Clarke, K
Nice, EC
Smyth, FE
Stockert, E
Richards, EC
Carr, FJ
Harris, WJ
Armour, KL
Rood, J
Kypridis, A
Kronina, V
Murphy, R
Lee, FT
Liu, ZQ
Kitamura, K
Ritter, G
Laughton, K
Hoffman, E
Burgess, AW
Old, LJ
Citation: Am. Scott et al., Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors, CANCER RES, 60(12), 2000, pp. 3254-3261
Authors:
Dullenkopf, W
Ritter, G
Fortunato, SR
Old, LJ
Schmidt, RR
Citation: W. Dullenkopf et al., Synthesis of a structurally defined antigen - Immunostimulant combination for use in cancer vaccines, CHEM-EUR J, 5(8), 1999, pp. 2432-2438
Authors:
Jungbluth, AA
Iversen, K
Coplan, K
Williamson, B
Chen, YT
Stockert, E
Old, LJ
Busam, KJ
Citation: Aa. Jungbluth et al., Expression of melanocyte-associated markers gp100 and Melan-A/MART-1 in angiomyolipomas - An immunohistochemical and rt-PCR analysis, VIRCHOWS AR, 434(5), 1999, pp. 429-435
Authors:
Doi, TS
Marino, MW
Takahashi, T
Yoshida, T
Sakakura, T
Old, LJ
Obata, Y
Citation: Ts. Doi et al., Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality (vol 96, pg 2994, 1999), P NAS US, 96(11), 1999, pp. 6571-6571
Authors:
Park, JE
Lenter, MC
Zimmermann, RN
Garin-Chesa, P
Old, LJ
Rettig, WJ
Citation: Je. Park et al., Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts, J BIOL CHEM, 274(51), 1999, pp. 36505-36512
Authors:
Jager, E
Stockert, E
Zidianakis, Z
Chen, YT
Karbach, J
Jager, D
Arand, M
Ritter, G
Old, LJ
Knuth, A
Citation: E. Jager et al., Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: Correlation with clinical events, INT J CANC, 84(5), 1999, pp. 506-510
Authors:
Jager, D
Stockert, E
Scanlan, MJ
Gure, AO
Jager, E
Knuth, A
Old, LJ
Chen, YT
Citation: D. Jager et al., Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: Characterization of tissue-specific ING1 transcripts and a homologue gene, CANCER RES, 59(24), 1999, pp. 6197-6204
Citation: Y. Noguchi et al., Regulation of IFN-gamma production in granulocyte-macrophage colony-stimulating factor-deficient mice, EUR J IMMUN, 28(12), 1998, pp. 3980-3988